Physician profile
Brian Holly
NPI 1386846277
$5,940.56
in general payments reported to CMS, 2019-2025
11 companies · $917 in 2025
The $917 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $318 · 2021: $603 · 2022: $354 · 2023: $257 · 2024: $2,664 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,556 · Travel and Lodging: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.67 |
| Travel and Lodging | $1,283.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,886.02 | 2019-2025 | Ruby Coil, Indigo System |
| Boston Scientific Corporation | $958.85 | 2019-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Terumo Medical Corporation | $246.69 | 2019-2025 | Azur Cx Detachable, Navicross |
| Ethicon US, LLC | $197.30 | 2020-2021 | |
| Inari Medical, INC. | $145.75 | 2020-2021 | |
| Medtronic Vascular, INC. | $123.99 | 2019 | |
| Imperative Care, INC | $111.21 | 2025 | Symphony Catheter |
| Abk Biomedical USA, INC. | $108.78 | 2025 | Eye90 Microspheres |
| Bard Peripheral Vascular, INC. | $95.99 | 2019 | |
| Biocompatibles, INC. | $41.40 | 2019 | |
| Angiodynamics, INC. | $24.58 | 2024 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Holly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.